Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Researchers perform massive and detailed cellular energy audit

Researchers perform massive and detailed cellular energy audit

Disrupted brain remapping causes spatial memory impairment in Alzheimer's

Disrupted brain remapping causes spatial memory impairment in Alzheimer's

Protective anti-prion antibodies found in humans

Protective anti-prion antibodies found in humans

Researchers use genome editing to facilitate drug discovery based on natural fungus

Researchers use genome editing to facilitate drug discovery based on natural fungus

West Virginia University performs revolutionary Alzheimer's treatment

West Virginia University performs revolutionary Alzheimer's treatment

Study: Amyloid-beta alters cholesterol biosynthesis in early stages of Alzheimer’s

Study: Amyloid-beta alters cholesterol biosynthesis in early stages of Alzheimer’s

Machine learning can increase effectiveness of drug repurposing for psychiatric disorders

Machine learning can increase effectiveness of drug repurposing for psychiatric disorders

Specific protein found at high levels in the blood of people with early signs of Alzheimer's

Specific protein found at high levels in the blood of people with early signs of Alzheimer's

Study validates new pharmacological target for Alzheimer’s disease

Study validates new pharmacological target for Alzheimer’s disease

Coronavirus changes structure that prevents cells from detecting it

Coronavirus changes structure that prevents cells from detecting it

Boosting metabolic resources in the brain could be a way to slow neurodegeneration

Boosting metabolic resources in the brain could be a way to slow neurodegeneration

Genes and cardiovascular health contribute to a person's dementia risk

Genes and cardiovascular health contribute to a person's dementia risk

Research may help design new, highly selective generation of Alzheimer's drugs

Research may help design new, highly selective generation of Alzheimer's drugs

Plant-based diet can help promote healthful aging and mitigate disease

Plant-based diet can help promote healthful aging and mitigate disease

A fine balance between maintaining immunity and longevity

A fine balance between maintaining immunity and longevity

Researchers use super-resolution microscopy to study close protein associations

Researchers use super-resolution microscopy to study close protein associations

TMEM106B gene reveals the causes of neurodegenerative diseases

TMEM106B gene reveals the causes of neurodegenerative diseases

Salmonella biofilm protein can cause autoimmunity and arthritis in animals

Salmonella biofilm protein can cause autoimmunity and arthritis in animals

CU scientists identify key role of  brain's immune cells during development

CU scientists identify key role of brain's immune cells during development

DNA repair tool is tailored to deal with specific type of complex break, study shows

DNA repair tool is tailored to deal with specific type of complex break, study shows

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.